Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH) was one of the biggest losers in post-Christmas trading. The stock dropped by 66.76% to close the day at $1.20. This followed news that the company had stopped taking in patients for its phase 2b CATALYST